FIGURE 3:

Multivariable-adjusted [adjusted for age, sex, BMI, initial dialysis therapy (haemodialysis or peritoneal dialysis), calendar year of dialysis start, diabetes, hypertension, myocardial infarction, stroke, peripheral vascular disease, heart failure, atrial fibrillation, ACEi/ARBs, beta-blockers, calcium blockers, ESA use, iron medication use, statins, phosphate binders, sodium bicarbonate, person-months with renal anaemia during their pre-ESKD phase and slope of eGFR decline during their pre-ESKD phase] associations between pre-ESKD mean ERI and the rate (hazard) of death and MACE+ during the first year after initiation of dialysis. ACEIs and ARBs, angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.